Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grégory Meiffren

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathwayGrégory Meiffren, Monique Flacher, Olga Azocar, et al.
Medecine Sciences : M/S|February 9, 2011
[Autophagy and pathogens: «Bon appétit Messieurs!»]Pierre-Emmanuel Joubert, Isabel Pombo Grégoire, Grégory Meiffren, et al.
Autophagy|January 21, 2010
Pathogen recognition by the cell surface receptor CD46 induces autophagyGrégory Meiffren, Pierre-Emmanuel Joubert, Isabel Pombo Grégoire, et al.
Diabetes, Obesity & Metabolism|June 21, 2018
Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetesGrit Andersen, Grégory Meiffren, Daniela Lamers, et al.
Diabetes, Obesity & Metabolism|January 12, 2023
A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetesGrit Andersen, Rosy Eloy, Susanne Famulla, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetesGrégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetesGrit Andersen, Grégory Meiffren, Susanne Famulla, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp studyTim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Cell Host & Microbe|October 20, 2009
Autophagy induction by the pathogen receptor CD46Pierre-Emmanuel Joubert, Grégory Meiffren, Isabel Pombo Grégoire, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathwayGrégory Meiffren, Monique Flacher, Olga Azocar, et al.
Medecine Sciences : M/S|February 9, 2011
[Autophagy and pathogens: «Bon appétit Messieurs!»]Pierre-Emmanuel Joubert, Isabel Pombo Grégoire, Grégory Meiffren, et al.
Autophagy|January 21, 2010
Pathogen recognition by the cell surface receptor CD46 induces autophagyGrégory Meiffren, Pierre-Emmanuel Joubert, Isabel Pombo Grégoire, et al.
Diabetes, Obesity & Metabolism|June 21, 2018
Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetesGrit Andersen, Grégory Meiffren, Daniela Lamers, et al.
Diabetes, Obesity & Metabolism|January 12, 2023
A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetesGrit Andersen, Rosy Eloy, Susanne Famulla, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetesGrégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetesGrit Andersen, Grégory Meiffren, Susanne Famulla, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp studyTim Heise, Grégory Meiffren, Bertrand Alluis, et al.
Cell Host & Microbe|October 20, 2009
Autophagy induction by the pathogen receptor CD46Pierre-Emmanuel Joubert, Grégory Meiffren, Isabel Pombo Grégoire, et al.
Pageof 1